Concord Biotech Limited

Concord Biotech Limited - Enterprise Valueverified

CONCORDBIO.NS

Price:

$1419

Market Cap:

$148.45B

Concord Biotech Limited, a biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsirolimus, everolimus, romidepsin, doxorubicin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment. In addition, the company provides mupirocin, mupirocin calciu...[Read more]

Industry

Biotechnology

IPO Date

2023-08-18

Stock Exchange

NSE

Ticker

CONCORDBIO.NS

The Enterprise Value as of August 2026 (TTM) for Concord Biotech Limited (CONCORDBIO.NS) is 148.34B

According to Concord Biotech Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 148.34B. This represents a change of 41.37% compared to the average of 104.93B of the last 4 quarters.

Concord Biotech Limited (CONCORDBIO.NS) Historical Enterprise Value (quarterly & annually)

How has CONCORDBIO.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Concord Biotech Limited over the last ten years is 119.01B. The current 148.34B Enterprise Value has changed 12.36% with respect to the historical average. Over the past ten years (40 quarters), CONCORDBIO.NS's Enterprise Value was at its highest in in the December 2024 quarter at 231.19B. The Enterprise Value was at its lowest in in the September 2022 quarter at 0.

Quarterly (TTM)
Annual

Average

119.01B

Median

99.48B

Minimum

98.69B

Maximum

173.98B

Concord Biotech Limited (CONCORDBIO.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Concord Biotech Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 57.34%

Maximum Annual Enterprise Value = 173.98B

Minimum Annual Increase = -38.43%

Minimum Annual Enterprise Value = 98.69B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2026107.11B-38.43%
2025173.98B11.79%
2024155.63B57.34%
202398.91B-0.34%
202299.25B-0.23%
202199.48B0.81%

Concord Biotech Limited (CONCORDBIO.NS) Average Enterprise Value

How has CONCORDBIO.NS Enterprise Value performed in the past?

The current Enterprise Value of Concord Biotech Limited (CONCORDBIO.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

145.58B

5-year avg

126.98B

10-year avg

119.01B

Concord Biotech Limited (CONCORDBIO.NS) Enterprise Value vs. Peers

How is CONCORDBIO.NS’s Enterprise Value compared to its peers?

Concord Biotech Limited’s Enterprise Value is greater than Blue Jet Healthcare Limited (101.65B), greater than Blue Jet Healthcare Limited (101.65B), less than Caplin Point Laboratories Limited (193.28B), greater than Jubilant Ingrevia Limited (117.00B), less than Natco Pharma Limited (154.71B), less than NATCO Pharma Limited (154.71B), less than Granules India Limited (217.53B), less than Granules India Limited (217.53B), less than Rainbow Children's Medicare Limited (164.84B), less than Rainbow Children's Medicare Limited (164.84B),

Build a custom stock screener for Concord Biotech Limited (CONCORDBIO.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Concord Biotech Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Concord Biotech Limited (CONCORDBIO.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Concord Biotech Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Concord Biotech Limited's Enterprise Value?

What is the highest Enterprise Value for Concord Biotech Limited (CONCORDBIO.NS)?

What is the 3-year average Enterprise Value for Concord Biotech Limited (CONCORDBIO.NS)?

What is the 5-year average Enterprise Value for Concord Biotech Limited (CONCORDBIO.NS)?

How does the current Enterprise Value for Concord Biotech Limited (CONCORDBIO.NS) compare to its historical average?